SHIVAS GILOTRA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FUQUAY VARINA, NC NPI 1972969913
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NC Amgen Inc. All categories
General Payments — all program years on this page
$2,734.70
- Category: General Payments
- Program years: PY2021–2024
- Record count: 76
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $244.40 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $244.40 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $141.72 | 2 |
| Novo Nordisk AS | $51.71 | 3 |
| Organon LLC | $20.92 | 1 |
| Acerta Pharma LLC | $16.69 | 1 |
| PFIZER INC. | $13.36 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100457750 | Novo Nordisk Inc | $17.09 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100472293 | Novo Nordisk Inc | $15.46 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100655555 | Novo Nordisk Inc | $19.16 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105550724 | AstraZeneca Pharmaceuticals LP | $16.69 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117261107 | Amgen Inc. | $125.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117562766 | Amgen Inc. | $16.72 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131214209 | PFIZER INC. | $13.36 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136209761 | Organon Llc | $20.92 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.